Therma Bright Inc. (THRM.V)
CAD 0.03
(20.0%)
CAD 0.03
(20.0%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | -3.67 Million CAD | 36.62% |
| 2022 | -5.82 Million CAD | 33.4% |
| 2021 | -8.55 Million CAD | -1305.93% |
| 2020 | -606.3 Thousand CAD | -51.77% |
| 2019 | -400.23 Thousand CAD | 67.64% |
| 2018 | -1.23 Million CAD | -28.07% |
| 2017 | -965.09 Thousand CAD | -369.52% |
| 2016 | -206.01 Thousand CAD | 41.37% |
| 2015 | -352.46 Thousand CAD | -149.36% |
| 2014 | 710.23 Thousand CAD | -50.41% |
| 2013 | 1.43 Million CAD | 645.75% |
| 2012 | -262.4 Thousand CAD | -35.52% |
| 2011 | -193.63 Thousand CAD | 0.0% |
| 2009 | -1.19 Million CAD | 25.0% |
| 2008 | -1.68 Million CAD | -31.07% |
| 2007 | -1.08 Million CAD | 26.05% |
| 2006 | -1.46 Million CAD | -29.92% |
| 2005 | -1.13 Million CAD | -66.85% |
| 2004 | -1.34 Million CAD | 0.0% |
| 2002 | -715.32 Thousand CAD | -603.64% |
| 2001 | -370.18 Thousand CAD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | -110.7 Thousand CAD | 94.17% |
| 2024 Q3 | -295.42 Thousand CAD | -244.19% |
| 2024 Q2 | -85.83 Thousand CAD | 26.4% |
| 2023 Q3 | -557.92 Thousand CAD | 16.16% |
| 2023 Q4 | -1.95 Million CAD | -250.28% |
| 2023 FY | - CAD | 36.62% |
| 2023 Q1 | -425.4 Thousand CAD | 53.35% |
| 2023 Q2 | -665.49 Thousand CAD | -56.44% |
| 2022 Q4 | -911.97 Thousand CAD | 3.92% |
| 2022 Q1 | -2.68 Million CAD | -127.81% |
| 2022 Q2 | -1.14 Million CAD | 57.45% |
| 2022 Q3 | -949.16 Thousand CAD | 16.83% |
| 2022 FY | - CAD | 33.4% |
| 2021 Q1 | -3.59 Million CAD | -713.49% |
| 2021 Q2 | -1.49 Million CAD | 58.43% |
| 2021 Q3 | -2.26 Million CAD | -51.4% |
| 2021 FY | - CAD | -1305.93% |
| 2021 Q4 | -1.17 Million CAD | 48.0% |
| 2020 Q3 | -47.49 Thousand CAD | 20.13% |
| 2020 FY | - CAD | -51.77% |
| 2020 Q1 | -57.85 Thousand CAD | -118.32% |
| 2020 Q2 | -59.45 Thousand CAD | -2.77% |
| 2020 Q4 | -442.32 Thousand CAD | -831.41% |
| 2019 Q4 | 315.75 Thousand CAD | 265.71% |
| 2019 Q3 | -190.54 Thousand CAD | 38.31% |
| 2019 Q2 | -308.84 Thousand CAD | -42.73% |
| 2019 Q1 | -216.39 Thousand CAD | 59.84% |
| 2019 FY | - CAD | 67.64% |
| 2018 FY | - CAD | -28.07% |
| 2018 Q4 | -538.86 Thousand CAD | -61.43% |
| 2018 Q3 | -333.8 Thousand CAD | -204.37% |
| 2018 Q2 | -109.66 Thousand CAD | 56.7% |
| 2018 Q1 | -253.24 Thousand CAD | 59.62% |
| 2017 Q4 | -627.19 Thousand CAD | -166.33% |
| 2017 Q3 | -235.49 Thousand CAD | -292.69% |
| 2017 Q2 | -59.97 Thousand CAD | -41.33% |
| 2017 Q1 | -42.43 Thousand CAD | -8741.96% |
| 2017 FY | - CAD | -369.52% |
| 2016 Q3 | -34.87 Thousand CAD | 32.67% |
| 2016 FY | - CAD | 41.37% |
| 2016 Q2 | -51.79 Thousand CAD | 56.61% |
| 2016 Q1 | -119.37 Thousand CAD | -89.0% |
| 2016 Q4 | 491.00 CAD | 101.41% |
| 2015 Q2 | -116.2 Thousand CAD | -34.74% |
| 2015 Q3 | -84.2 Thousand CAD | 27.54% |
| 2015 Q4 | -63.16 Thousand CAD | 24.99% |
| 2015 Q1 | -86.24 Thousand CAD | -109.2% |
| 2015 FY | - CAD | -149.36% |
| 2014 FY | - CAD | -50.41% |
| 2014 Q2 | -69.01 Thousand CAD | 4.78% |
| 2014 Q4 | 937.88 Thousand CAD | 1188.43% |
| 2014 Q3 | -86.16 Thousand CAD | -24.86% |
| 2014 Q1 | -72.47 Thousand CAD | -104.53% |
| 2013 Q4 | 1.59 Million CAD | 2896.05% |
| 2013 FY | - CAD | 645.75% |
| 2013 Q1 | -54.73 Thousand CAD | 66.69% |
| 2013 Q3 | -57.17 Thousand CAD | -4.52% |
| 2013 Q2 | -54.7 Thousand CAD | 0.06% |
| 2012 Q1 | -38.63 Thousand CAD | 0.0% |
| 2012 Q4 | -164.34 Thousand CAD | -501.28% |
| 2012 Q2 | -32.39 Thousand CAD | 16.14% |
| 2012 FY | - CAD | -35.52% |
| 2012 Q3 | -27.33 Thousand CAD | 15.63% |
| 2011 FY | - CAD | 0.0% |
| 2010 Q1 | -17.00 CAD | 100.0% |
| 2010 Q2 | -60.74 Thousand CAD | -357200.0% |
| 2010 Q3 | -48.04 Thousand CAD | 20.9% |
| 2009 Q3 | -139.57 Thousand CAD | 50.75% |
| 2009 Q1 | -213.75 Thousand CAD | 62.01% |
| 2009 Q4 | -623.92 Thousand CAD | -347.02% |
| 2009 FY | - CAD | 25.0% |
| 2009 Q2 | -283.37 Thousand CAD | -32.57% |
| 2008 FY | - CAD | -31.07% |
| 2008 Q4 | -562.64 Thousand CAD | -257.29% |
| 2008 Q3 | -157.47 Thousand CAD | 54.0% |
| 2008 Q2 | -342.33 Thousand CAD | 13.19% |
| 2008 Q1 | -394.36 Thousand CAD | -11.15% |
| 2007 Q3 | -181.77 Thousand CAD | 32.34% |
| 2007 Q4 | -354.81 Thousand CAD | -95.2% |
| 2007 Q2 | -268.65 Thousand CAD | 5.42% |
| 2007 Q1 | -284.03 Thousand CAD | 48.68% |
| 2007 FY | - CAD | 26.05% |
| 2006 Q4 | -553.41 Thousand CAD | -28.16% |
| 2006 FY | - CAD | -29.92% |
| 2006 Q2 | -245.64 Thousand CAD | -20.36% |
| 2006 Q1 | -204.09 Thousand CAD | 28.34% |
| 2006 Q3 | -431.83 Thousand CAD | -75.8% |
| 2005 Q2 | -351.53 Thousand CAD | -45.38% |
| 2005 Q4 | -284.83 Thousand CAD | -12.58% |
| 2005 Q3 | -252.99 Thousand CAD | 28.03% |
| 2005 FY | - CAD | -66.85% |
| 2005 Q1 | -241.81 Thousand CAD | 0.0% |
| 2004 FY | - CAD | 0.0% |
| 2004 Q3 | -506.95 Thousand CAD | -332.43% |
| 2004 Q1 | -78.36 Thousand CAD | 46.63% |
| 2004 Q2 | -117.23 Thousand CAD | -49.59% |
| 2003 Q4 | -146.83 Thousand CAD | -15.43% |
| 2003 Q2 | -114.51 Thousand CAD | 58.78% |
| 2003 Q1 | -277.82 Thousand CAD | -49.28% |
| 2003 Q3 | -127.2 Thousand CAD | -11.09% |
| 2002 Q4 | -186.11 Thousand CAD | -23.08% |
| 2002 FY | - CAD | -603.64% |
| 2002 Q2 | -97.99 Thousand CAD | 0.0% |
| 2002 Q3 | -151.2 Thousand CAD | -54.3% |
| 2001 FY | - CAD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Perimeter Medical Imaging AI, Inc. | -17.91 Million CAD | 79.47% |
| Theralase Technologies Inc. | -4.25 Million CAD | 13.525% |
| VentriPoint Diagnostics Ltd. | -4.73 Million CAD | 22.364% |